| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally …
Over the last 12 months, insiders at XTL Biopharmaceuticals Ltd. have bought $0 and sold $0 worth of XTL Biopharmaceuticals Ltd. stock.
On average, over the past 5 years, insiders at XTL Biopharmaceuticals Ltd. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 51,000 shares for transaction amount of $164,730 was made by EDELMAN JOSEPH (10 percent owner) on 2008‑06‑10.
| 2008-11-19 | Sale | EDELMAN JOSEPH | 10 percent owner | 9.6M 6.44% | $0.15 | $1.47M | +40.00% | |
| 2008-11-18 | Sale | EDELMAN JOSEPH | 10 percent owner | 30.45M 19.0502% | $0.14 | $4.34M | +7.69% | |
| 2008-06-10 | EDELMAN JOSEPH | 10 percent owner | 51,000 0.7232% | $3.23 | $164,730 | -92.26% | ||
| 2008-06-09 | EDELMAN JOSEPH | 10 percent owner | 33,600 0.4956% | $3.36 | $112,896 | -92.63% | ||
| 2008-06-06 | EDELMAN JOSEPH | 10 percent owner | 100,000 1.5059% | $3.43 | $343,000 | -92.84% | ||
| 2008-06-05 | EDELMAN JOSEPH | 10 percent owner | 300,000 4.2453% | $3.22 | $967,000 | -92.75% | ||
| 2008-06-04 | EDELMAN JOSEPH | 10 percent owner | 25,000 0.3282% | $2.99 | $74,750 | -91.61% | ||
| 2008-06-03 | EDELMAN JOSEPH | 10 percent owner | 400,730 5.3307% | $3.03 | $1.21M | -91.75% | ||
| 2008-05-02 | EDELMAN JOSEPH | 10 percent owner | 50,000 0.8517% | $3.88 | $194,000 | -40.41% | ||
| 2008-05-01 | EDELMAN JOSEPH | 10 percent owner | 105,000 1.7287% | $3.75 | $393,750 | -40.21% | ||
| 2008-04-30 | EDELMAN JOSEPH | 10 percent owner | 128,370 2.1099% | $3.74 | $480,579 | -38.42% | ||
| 2008-04-29 | EDELMAN JOSEPH | 10 percent owner | 229,240 3.5606% | $3.54 | $811,028 | -37.30% | ||
| 2008-04-10 | EDELMAN JOSEPH | 10 percent owner | 100,000 1.5699% | $3.58 | $357,590 | -21.02% | ||
| 2008-04-01 | EDELMAN JOSEPH | 10 percent owner | 301,000 4.1792% | $3.16 | $951,913 | -2.87% | ||
| 2008-03-28 | EDELMAN JOSEPH | 10 percent owner | 25,000 0.3181% | $2.90 | $72,460 | +2.34% | ||
| 2008-03-18 | EDELMAN JOSEPH | 10 percent owner | 163,000 2.2329% | $3.12 | $508,593 | -1.89% | ||
| 2008-03-14 | EDELMAN JOSEPH | 10 percent owner | 463,000 6.7626% | $3.33 | $1.54M | -6.55% | ||
| 2008-03-13 | EDELMAN JOSEPH | 10 percent owner | 247,000 3.6626% | $3.38 | $834,234 | -9.25% | ||
| 2008-03-12 | EDELMAN JOSEPH | 10 percent owner | 440,000 6.4821% | $3.36 | $1.48M | -6.40% | ||
| 2008-03-11 | EDELMAN JOSEPH | 10 percent owner | 619,000 8.9963% | $3.31 | $2.05M | -5.69% |
| Increased Positions | 4 | +80% | 111,838 | +49.28% |
| Decreased Positions | 2 | -40% | 9,034 | -3.98% |
| New Positions | 3 | New | 98,991 | New |
| Sold Out Positions | <1 | Sold Out | 763 | Sold Out |
| Total Postitions | 7 | +40% | 329,727 | +45.3% |
| Noked Israel Ltd | $119.00 | 2.21% | 198,888 | 0 | 0% | 2025-09-30 |
| Rhumbline Advisers | $10.00 | 0.19% | 17,261 | 0 | 0% | 2025-09-30 |
| Gamma Investing Llc | $8.00 | 0.14% | 12,887 | +12,887 | New | 2025-12-31 |
| Morgan Stanley | $6.00 | 0.11% | 10,011 | -1,000 | -9.08% | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 763 | -573 | -42.89% | 2025-09-30 |